These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8862894)

  • 41. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.
    Kohler MF; Nishii H; Humphrey PA; Saski H; Marks J; Bast RC; Clarke-Pearson DL; Boyd J; Berchuck A
    Am J Obstet Gynecol; 1993 Sep; 169(3):690-4. PubMed ID: 8372881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Preliminary study on gene expression profile of endometrial adenocarcinoma].
    Zhou HJ; Shi YF; Li JQ; Cui JQ
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):464-7. PubMed ID: 14575571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of replication error positive phenotype with lymphocyte infiltration in endometrial cancers.
    Kihana T; Fujioka T; Hamada K; Kito K; Takahashi A; Tsukayama C; Ito M
    Jpn J Cancer Res; 1998 Sep; 89(9):895-902. PubMed ID: 9818024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microsatellite instability and immunohistochemical analysis of MLH1 and MSH2 in normal endometrium, endometrial hyperplasia and endometrial cancer from a hereditary nonpolyposis colorectal cancer patient.
    Ichikawa Y; Tsunoda H; Takano K; Oki A; Yoshikawa H
    Jpn J Clin Oncol; 2002 Mar; 32(3):110-2. PubMed ID: 11956307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular profiles of benign and (pre)malignant endometrial lesions.
    van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG
    Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The postman always rings twice, so does the receptor].
    Birnbaum D; Pébusque MJ; Coulier F
    Bull Cancer; 1997 Dec; 84(12):1143-5. PubMed ID: 9587368
    [No Abstract]   [Full Text] [Related]  

  • 47. Molecular pathology of endometrial hyperplasia and carcinoma.
    Matias-Guiu X; Catasus L; Bussaglia E; Lagarda H; Garcia A; Pons C; Muñoz J; Argüelles R; Machin P; Prat J
    Hum Pathol; 2001 Jun; 32(6):569-77. PubMed ID: 11431710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor invasion and metastasis--nature or nurture?
    Rosser RJ
    Hum Pathol; 2001 Dec; 32(12):1416-7. PubMed ID: 11774182
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chromosomes in adenomatous hyperplasia and adenocarcinoma of the endometrium].
    Bonilla-Musoles F
    Z Geburtshilfe Gynakol; 1971 Dec; 175(3):218-25. PubMed ID: 5157072
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers.
    Susumu N; Aoki D; Noda T; Nagashima Y; Hirao T; Tamada Y; Banno K; Suzuki A; Suzuki N; Tsuda H; Inazawa J; Nozawa S
    Int J Gynecol Cancer; 2005; 15(1):70-80. PubMed ID: 15670300
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apoptosis and the expression of Bax and Bcl-2 in hyperplasia and adenocarcinoma of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Hum Reprod; 2001 Oct; 16(10):2211-8. PubMed ID: 11574518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of telomerase genes as potential marker of neoplastic changes.
    Mazurek U; Witek A; Olejek A; Paul M; Skałba P; Wilczok T
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():183-4. PubMed ID: 11820598
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of hCG and GnRHs and their receptors in endometrial carcinoma and hyperplasia.
    Jankowska AG; Andrusiewicz M; Fischer N; Warchol PJ
    Int J Gynecol Cancer; 2010 Jan; 20(1):92-101. PubMed ID: 20130508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial endometrial adenocarcinoma.
    Sandles LG
    Clin Obstet Gynecol; 1998 Mar; 41(1):167-71. PubMed ID: 9504234
    [No Abstract]   [Full Text] [Related]  

  • 55. p53lyn and p56lyn: a new signaling pathway in human endometrium and endometrial adenocarcinomas.
    Couchman GM; Bentley R; Tsao MS; Raszmann K; McLachlan JA; Walmer DK
    J Soc Gynecol Investig; 1997; 4(2):103-9. PubMed ID: 9101470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CYP17 genetic polymorphism in patients with endometrial hyperplasia and cancer.
    Aban M; Arslan M; Tok E; Tekes S; Budak T; Altintas A
    Int J Gynecol Cancer; 2006; 16 Suppl 1():448-51. PubMed ID: 16515644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors in endometrial neoplasia: old and new.
    Nogales FF
    Curr Opin Obstet Gynecol; 1996 Feb; 8(1):74-8. PubMed ID: 8777263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer.
    Esteller M; García A; Martínez-Palones JM; Xercavins J; Reventós J
    Eur J Cancer; 1997 Sep; 33(10):1572-7. PubMed ID: 9389917
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Aromatase activities of endometrial carcinomas and both basic and clinical analyses of endometrial hyperplasia as a premalignant disease].
    Sasaki H
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Aug; 45(8):763-75. PubMed ID: 8371007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bax, Bcl-2, and p53 expression in endometrial cancer.
    Sakuragi N; Salah-eldin AE; Watari H; Itoh T; Inoue S; Moriuchi T; Fujimoto S
    Gynecol Oncol; 2002 Sep; 86(3):288-96. PubMed ID: 12217750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.